Publishers NoteSynthesis and antitumor activity of the 7-O-(2,6-dideoxy-2-fluoro-α-l-talopyranosyl)daunomycinone derivatives modified at C-3′ or C-4′

Add time:08/23/2019    Source:sciencedirect.com

As a part of a study to exploit anthracycline glycosides effective against resistant tumor cells, the 3′-O-methyl (3), 4′-O-methyl (4), 3′-deoxy (6), 3′-deoxy-3′-fluoro (7), and 3′-deoxy-3′-iodo (8) derivatives of 7-O-(2,6-dideoxy-2-fluoro-α-l-talopyranosyl)daunomycinone have been prepared by coupling suitably protected glycosyl bromides with daunomycinone. The doxorubicin-type analog (5) of 4 was also prepared. Among the compounds prepared, 5 showed the highest antitumor activity. Relationships between chemical structures of the synthetic products and antitumor activities, together with the degree of resistance were discussed.

We also recommend Trading Suppliers and Manufacturers of 7-O-(3-amino-2,3,6-trideoxy-alpha-hexopyranosyl)-epsilon-isorhodomycinone (cas 117016-15-6). Pls Click Website Link as below: cas 117016-15-6 suppliers

Prev:Conformational analysis of 4-demethoxy-7-O-[2,6-dideoxy-4-O-(2,3,6-trideoxy-3-amino-α-l-lyxo-hexopyranosyl)- α-l-lyxo-hexopyranosyl]adriamicinone, the first doxorubicin disaccharide analogue to be reported
Next:Assessment of the κ-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens)